₹190
(Inclusive of all Taxes)
₹28.5 Cashback (15%)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
DROTAVERINE-80MG + MEFENAMIC ACID-250MG
Manufacturer/Marketer :
Dey's Medical Stores (Mfg) Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Spadrot-M Tablet:
Coadministration of Spadrot-M Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Spadrot-M Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Spadrot-M Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Spadrot-M Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Critical
How does the drug interact with Spadrot-M Tablet:
Co-administration of Spadrot-M Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Spadrot-M Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Co-administration of Spadrot-M Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Spadrot-M Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Severe
How does the drug interact with Spadrot-M Tablet:
Combining Spadrot-M Tablet with Dalteparin can increase the risk of bleeding and hemorrhage.
How to manage the interaction:
Although taking Dalteparin and Spadrot-M Tablet together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any signs like bleeding, bruising, swelling, vomiting, headache, dizziness, weakness, or blood in your urine or stool, make sure to contact your doctor right away. Do not stop using any medications without talking to a doctor.
Combining Spadrot-M Tablet with Dalteparin can increase the risk of bleeding and hemorrhage.
How to manage the interaction:
Although taking Dalteparin and Spadrot-M Tablet together can cause an interaction, it can be taken if your doctor has suggested it. If you notice any signs like bleeding, bruising, swelling, vomiting, headache, dizziness, weakness, or blood in your urine or stool, make sure to contact your doctor right away. Do not stop using any medications without talking to a doctor.
How does the drug interact with Spadrot-M Tablet:
Coadministration of Spadrot-M Tablet with Leflunomide can increase the risk or severity of liver disease.
How to manage the interaction:
Taking Spadrot-M Tablet with Leflunomide together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Spadrot-M Tablet with Leflunomide can increase the risk or severity of liver disease.
How to manage the interaction:
Taking Spadrot-M Tablet with Leflunomide together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of fever, chills, joint pain or swelling, unusual bleeding or bruising, skin rash, itching, loss of appetite, fatigue, nausea, vomiting, dark-colored urine, light-colored stools, and/or yellowing of the skin or eyes, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Spadrot-M Tablet:
Teriflunomide may cause liver damage and taking it with Spadrot-M Tablet may increase that risk.
How to manage the interaction:
Although taking Spadrot-M Tablet and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
Teriflunomide may cause liver damage and taking it with Spadrot-M Tablet may increase that risk.
How to manage the interaction:
Although taking Spadrot-M Tablet and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Spadrot-M Tablet:
Coadministration of Spadrot-M Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Spadrot-M Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Spadrot-M Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Spadrot-M Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Spadrot-M Tablet:
The combined use of Spadrot-M Tablet and Tenofovir alafenamide can increase the risk of kidney problems.
How to manage the interaction:
Taking Spadrot-M Tablet and Tenofovir alafenamide together can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
The combined use of Spadrot-M Tablet and Tenofovir alafenamide can increase the risk of kidney problems.
How to manage the interaction:
Taking Spadrot-M Tablet and Tenofovir alafenamide together can lead to an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, bone pain, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, contact a doctor immediately. Do not discontinue any medications without consulting a doctor.
Mefenamic acidDanaparoid
Severe
How does the drug interact with Spadrot-M Tablet:
Using danaparoid together with Spadrot-M Tablet can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possibility of interaction between Spadrot-M Tablet and Danaparoid, but it can be taken if prescribed by a doctor. If you notice any of these signs - bruising, swelling, vomiting, headache, dizziness, weakness, bleeding, or blood in your urine or stools, it's important to contact a doctor right away. Do not discontinue any medications without consulting a doctor.
Using danaparoid together with Spadrot-M Tablet can increase the risk of bleeding complications.
How to manage the interaction:
There may be a possibility of interaction between Spadrot-M Tablet and Danaparoid, but it can be taken if prescribed by a doctor. If you notice any of these signs - bruising, swelling, vomiting, headache, dizziness, weakness, bleeding, or blood in your urine or stools, it's important to contact a doctor right away. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Spadrot-M Tablet:
Taking Human immunoglobulin with Spadrot-M Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Spadrot-M Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with Spadrot-M Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Spadrot-M Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with Spadrot-M Tablet:
Coadministration of Spadrot-M Tablet with Everolimus can increase the risk or severity of kidney disease.
How to manage the interaction:
Taking Spadrot-M Tablet with Everolimus together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Spadrot-M Tablet with Everolimus can increase the risk or severity of kidney disease.
How to manage the interaction:
Taking Spadrot-M Tablet with Everolimus together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
Alcohol
Unsafe
Avoid consumption of alcohol while taking Spadrot-M Tablet as it may cause increased drowsiness. It can also increase the risk of stomach bleeding.
Pregnancy
Caution
Please consult your doctor if you are pregnant or if you have any concerns regarding this; your doctor will prescribe only if the benefits outweigh the risks.
Breast Feeding
Caution
Consult your doctor before taking Spadrot-M Tablet if you are breastfeeding. Your doctor will prescribe only if the benefits outweigh the risks.
Driving
Caution
Spadrot-M Tablet may cause drowsiness. Drive or operate machinery only if you are alert.
Liver
Caution
Please consult your doctor if you have a liver impairment or any concerns regarding this. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Please consult your doctor if you have kidney impairment or any concerns regarding this. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Spadrot-M Tablet should not be given to children as the safety and effectiveness were not established.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
